**Core tip:** The mortality-to-incidence ratios (MIRs), defined as the ratio of the crude rate of mortality to the incidence, could reflect the clinical outcomes of disease. A total of 57 countries was included in this analysis to evaluate the association between MIR and health care disparities. The results showed the more developed regions had high gastric cancer incidence and mortality, but lower MIR than the less developed regions. Otherwise, good World Health Organization ranking and high total expenditures on health/gross domestic product were significantly associated with low MIRs. Therefore, the MIR variation for gastric cancer could predict regional health disparities.

INTRODUCTION
============

Gastric cancer was the leading cause of cancer mortality worldwide until the 1990s\[[@B1]\], but its incidence has since declined, especially in the developed world. Nevertheless, gastric cancer remains one of the most prevalent cancers in the world\[[@B2],[@B3]\]. Gastric cancer is a multi-factorial disease, having a clear relationship with environmental risks, dietary habits, food storage, *Helicobacter pylori* infection, and geographic region\[[@B4]-[@B8]\]. Gastric cancer is more common in developing countries than in developed countries, and it occurs more frequently in men than in women\[[@B7],[@B8]\].

Previous ethnic and migration studies have indicated that early exposure to environmental factors has a greater influence on the mortality and incidence rates of gastric cancer than is found for genetic factors\[[@B9],[@B10]\]. Modern studies have also explored the mechanism of how *Helicobacter pylori* infection affects gastric cancer development in cancer stem cell lines and animal models\[[@B11],[@B12]\]. Several recent large-scale database observational studies have documented the incidence of gastric cancer among patients with gastric precancerous lesions in western countries\[[@B13],[@B14]\]. The early detection of precancerous lesions, such as atrophic gastritis, intestinal metaplasia and dysplasia, by esophagogastroduodenoscopy (EGD) and further endoscopic or surgical resection are helping to decrease the progression to malignancy\[[@B15]\] and therefore the morbidity and mortality associated with gastric cancer.

As already mentioned, the mortality rates due to gastric cancer have shown a steady decline globally, but regional differences are evident. Previous studies have demonstrated an annual percent decrease in gastric mortality rate of around 3% to 4% for European countries, the United States, the Republic of Korea, Japan and Australia between 1980 and 2005\[[@B16]\]. A 2% annual percent decrease was noted in gastric mortality rate among major Latin American countries and a less dramatic decline was observed in China\[[@B2]\]. This decline is at least in part due to the introduction of EGD, an important tool for early detection of gastric cancer, and even precancerous lesions. A recent Japanese study concluded that EGD screening was more powerful than either radiographic or photofluorography screening, and reduced the mortality rate from gastric cancer by 57%\[[@B17]\].

All these declines in gastric cancer prevalence suggest that the health care system may be able to improve precancerous lesion detection, early cancer detection, and treatment of gastric cancer to provide further declines in mortality. We therefore considered that the mortality-to-incidence (MIR) ratio for gastric cancer should be low in countries with good health care systems, in agreement with recent findings on prostate cancer\[[@B18]-[@B21]\]. The aim of the present study was therefore to clarify the association between human development, the World Health Organization (WHO) ranking, region, total expenditure on health/gross domestic product (GDP; e/GDP), life expectancy, and crude rates of incidence and mortality for gastric cancer in different countries. Our results provide a comprehensive overview of gastric cancer MIRs and health disparities in various countries across the globe.

MATERIALS AND METHODS
=====================

The data acquisition was described previously\[[@B18]\]. In brief, the cancer epidemiological data were gathered from the GLOBOCAN 2012 database maintained by the International Agency for Research on Cancer (https://[www.iarc.fr/](www.iarc.fr/)). The WHO rankings of countries were obtained from the World's Health Systems of WHO. The e/GDP and life expectancies for 2012 were obtained from the World Health Statistics 2015.

Data for 184 countries were obtained from the GLOBOCAN 2012 database. Among these 184 countries, 22 were excluded from the study due to a lack of WHO ranking data. We excluded a further 105 countries due to the availability of mortality/incidence data mentioned in GLOBOCAN 2012 database (rankings E to G for incidence or rankings 4 to 6 for mortality were excluded). This resulted in 57 countries being further analyzed in this study. The MIR is defined as the ratio of the crude rate of mortality and the crude rate of incidence\[[@B21]\].

The methods used for statistical analyses were described previously\[[@B18]\]. Associations between the MIRs and variants among countries were estimated by linear regression. R-squared changes and analysis of variance (ANOVA) were determined using SPSS statistical software version 15.0 (SPSS, Inc., Chicago, IL, United States). *P* value \< 0.05 of a two-sided test were considered statistically significant. Scatter plots were generated using Microsoft Excel 2010.

RESULTS
=======

Incidence and mortality rates of gastric cancer according to regions
--------------------------------------------------------------------

We examined the global trends in gastric cancer by analyzing the incidence and mortality numbers and rates according to different regions across the globe. The results are summarized in Table [1](#T1){ref-type="table"}. The worldwide MIR is 0.76 and it is higher in less developed regions than in more developed regions (0.80 *vs* 0.64). The WHO values indicate that the Western Pacific region has the highest incidence and mortality for gastric cancer, regardless of whether this is based on the number, crude rate, or age-standardized rate (ASR) (Table [1](#T1){ref-type="table"}). However, this region has the lowest MIR, at 0.72, among the six WHO regions. The highest MIR is reported for the WHO South-East Asia region (0.92). At a continent level, Africa has the lowest rate of incidence but has the highest MIR (0.91). The lowest MIR is found in North America.

###### 

Case number, rate and mortality-to-incidence ratio of the incidence and mortality of gastric cancer according to region

  **Region**                      **Number**   **Crude rate**   **Age-standardized rate**   **Mortality-to-incidence ratio[1](#T1FN1){ref-type="table-fn"}**                 
  ------------------------------- ------------ ---------------- --------------------------- ------------------------------------------------------------------ ------ ------ ------
  World                           951594       723073           13.5                        10.2                                                               12.1   8.9    0.76
  Development                                                                                                                                                                
  More developed regions          274509       174756           22.0                        14.0                                                               10.6   6.4    0.64
  Less developed regions          677085       548317           11.7                        9.4                                                                12.7   10.2   0.80
  WHO region categories                                                                                                                                                      
  WHO Africa region               19110        17589            2.2                         2.0                                                                4.0    3.7    0.91
  WHO Americas region             85354        65130            8.9                         6.8                                                                6.9    5.1    0.76
  WHO East Mediterranean region   23454        20789            3.8                         3.3                                                                5.5    4.9    0.87
  WHO Europe region               161846       126315           17.9                        14.0                                                               10.0   7.4    0.78
  WHO South-East Asia region      90558        83249            4.9                         4.5                                                                5.7    5.3    0.92
  WHO Western Pacific region      571139       409897           31.0                        22.2                                                               22.8   15.7   0.72
  Continent                                                                                                                                                                  
  Africa                          23806        21801            2.2                         2.0                                                                3.8    3.5    0.91
  Latin America and Caribbean     60852        51435            10.1                        8.5                                                                9.7    8.1    0.84
  Northern America                24502        13695            7.0                         3.9                                                                4.0    2.1    0.56
  Asia                            699954       527074           16.5                        12.4                                                               15.8   11.7   0.75
  Europe                          139667       107360           18.8                        14.5                                                               9.4    6.9    0.77
  Oceania                         2813         1708             7.5                         4.5                                                                5.1    3.0    0.60

The percentage in the ratio of the crude rate of mortalities and the crude rate of incidences.

WHO ranking and e/GDP were significantly associated with the MIRs for gastric cancer
------------------------------------------------------------------------------------

We conducted a further comparison of the differences in epidemiology among countries by analyzing the 57 selected countries (Table [2](#T2){ref-type="table"}). The e/GDP ranged from 2.7% (Oman) to 17.0% (United States of America) with mean ± standard deviation of 8.0% ± 2.6%. Japan had the longest life expectancy (84 years) and the Republic of South Africa had the shortest (60 years). Japan had the highest crude rates for gastric cancer, at 85.3 and 41.4 for incidence and mortality respectively. The MIR of Japan, at 0.49, was the fourth lowest value among the 57 countries. The lowest MIR was found for the Republic of Korea (0.34), which had the highest gastric cancer incidence in terms of ASR (41.8). Among these countries, five have MIR values greater than or equal to 0.90, including Fiji (1.05), Ecuador (0.94), Mauritius (0.92), Chile (0.91) and Egypt (0.90).

###### 

World Health Organization rankings, total expenditure on health/ gross domestic product, life expectancy, gastric cancer incidence, mortality and mortality-to-incidence ratio for gastric cancer in selected countries

  **Country**           **Ranking**   **Total expenditure on health/GDP, %**   **Life expectancy**   **Number**   **Crude rate**   **Age-standardized rate**   **Mortality-to-incidence ratio[1](#T2FN1){ref-type="table-fn"}**                 
  --------------------- ------------- ---------------------------------------- --------------------- ------------ ---------------- --------------------------- ------------------------------------------------------------------ ------ ------ ------
  France                1             11.6                                     82                    6507         4412             10.3                        7                                                                  4.7    2.9    0.68
  Italy                 2             9.2                                      83                    13001        9917             21.3                        16.3                                                               8.2    5.6    0.77
  Malta                 5             8.7                                      81                    68           33               16.2                        7.9                                                                8.0    3.3    0.49
  Singapore             6             4.2                                      83                    647          431              12.3                        8.2                                                                8.2    5.3    0.67
  Spain                 7             9.3                                      83                    7810         5389             16.7                        11.5                                                               7.8    4.9    0.69
  Oman                  8             2.7                                      76                    79           68               2.7                         2.3                                                                5.3    4.7    0.85
  Austria               9             11.1                                     81                    1314         853              15.6                        10.1                                                               6.8    4.0    0.65
  Japan                 10            10.3                                     84                    107898       52326            85.3                        41.4                                                               29.9   12.4   0.49
  Norway                11            9.3                                      82                    475          311              9.6                         6.3                                                                4.6    2.8    0.66
  Portugal              12            9.9                                      81                    3018         2285             28.2                        21.4                                                               13.1   9.0    0.76
  Iceland               15            9.0                                      82                    28           18               8.5                         5.5                                                                5.0    2.9    0.65
  Luxembourg            16            7.2                                      82                    67           32               12.8                        6.1                                                                7.6    3.0    0.48
  Netherlands           17            12.7                                     81                    1953         1391             11.7                        8.3                                                                5.6    3.7    0.71
  United Kingdom        18            9.3                                      81                    6684         4534             10.6                        7.2                                                                4.7    2.9    0.68
  Ireland               19            8.9                                      81                    487          325              10.6                        7.1                                                                6.5    4.2    0.67
  Switzerland           20            11.4                                     83                    683          485              8.8                         6.3                                                                4.2    2.6    0.72
  Belgium               21            10.9                                     80                    1417         962              13.1                        8.9                                                                5.8    3.5    0.68
  Colombia              22            6.8                                      78                    5897         4981             12.4                        10.5                                                               13.4   11.2   0.85
  Sweden                23            9.6                                      82                    811          635              8.5                         6.7                                                                3.7    2.7    0.79
  Cyprus                24            7.3                                      82                    94           72               8.3                         6.4                                                                5.4    4.0    0.77
  Germany               25            11.3                                     81                    16015        9714             19.5                        11.8                                                               7.8    4.3    0.61
  Israel                28            7.4                                      82                    777          516              10.1                        6.7                                                                7.1    4.5    0.66
  Canada                30            10.9                                     82                    3342         1937             9.6                         5.6                                                                4.9    2.7    0.58
  Finland               31            9.1                                      81                    641          479              11.9                        8.9                                                                5.2    3.7    0.75
  Australia             32            8.9                                      83                    2049         1135             8.9                         5.0                                                                4.8    2.5    0.56
  Chile                 33            7.3                                      80                    3712         3371             21.3                        19.3                                                               15.6   13.8   0.91
  Denmark               34            11.0                                     80                    625          351              11.2                        6.3                                                                5.6    2.9    0.56
  Costa Rica            36            10.1                                     79                    874          612              18.2                        12.8                                                               17.3   12     0.70
  United States         37            17.0                                     79                    21155        11758            6.7                         3.7                                                                3.9    2.0    0.55
  Slovenia              38            9.4                                      80                    468          335              22.9                        16.4                                                               10.4   6.8    0.72
  Cuba                  39            8.6                                      78                    1126         916              10.0                        8.1                                                                5.9    4.6    0.81
  New Zealand           41            10.2                                     82                    393          240              8.8                         5.4                                                                5.2    2.9    0.61
  Bahrain               46            4.4                                      77                    29           21               2.1                         1.5                                                                3.9    3.5    0.71
  Thailand              47            4.5                                      75                    2841         2286             4.1                         3.3                                                                3.1    2.5    0.80
  Czech Republic        48            7.5                                      78                    1595         1099             15.1                        10.4                                                               7.4    4.9    0.69
  Malaysia              49            4.0                                      74                    1900         873              6.5                         3.0                                                                7.8    3.6    0.46
  Poland                50            6.8                                      77                    6105         5197             15.9                        13.6                                                               8.4    7.0    0.86
  Jamaica               53            5.6                                      74                    269          229              9.7                         8.3                                                                9.1    7.1    0.86
  South Korea           58            7.6                                      82                    31269        10746            64.4                        22.1                                                               41.8   13     0.34
  Philippines           60            4.4                                      69                    2415         2043             2.5                         2.1                                                                3.8    3.3    0.84
  Slovakia              62            8.1                                      76                    901          633              16.4                        11.6                                                               9.6    6.5    0.71
  Egypt                 63            4.9                                      71                    1789         1584             2.1                         1.9                                                                2.5    2.3    0.90
  Uruguay               65            8.6                                      77                    577          514              17.0                        15.2                                                               10     8.4    0.89
  Trinidad and Tobago   67            5.5                                      71                    67           53               5.0                         3.9                                                                4.4    3.4    0.78
  Belarus               72            5.0                                      72                    2961         2495             31.1                        26.2                                                               18.8   15.3   0.84
  Lithuania             73            6.7                                      74                    867          668              26.3                        20.3                                                               13.8   10.2   0.77
  Argentina             75            6.8                                      76                    3738         3273             9.1                         8.0                                                                6.7    5.7    0.88
  Estonia               77            5.9                                      77                    370          286              27.6                        21.3                                                               13.8   9.7    0.77
  Ukraine               79            7.5                                      71                    11373        9216             25.3                        20.5                                                               14.3   11.6   0.81
  Mauritius             84            4.8                                      74                    121          112              9.2                         8.5                                                                8      7.4    0.92
  Fiji                  96            4.0                                      70                    18           19               2.1                         2.2                                                                2.4    2.6    1.05
  Bulgaria              102           7.4                                      75                    1664         1354             22.5                        18.3                                                               10.3   8.3    0.81
  Latvia                105           5.9                                      74                    640          484              28.6                        21.7                                                               14.3   10.2   0.76
  Ecuador               111           6.4                                      76                    2401         2262             16.2                        15.2                                                               16.9   15.5   0.94
  Brazil                125           9.5                                      75                    19690        16077            9.9                         8.1                                                                9.2    7.4    0.82
  Russian Federation    130           6.5                                      69                    38417        32854            26.9                        23                                                                 16     13.1   0.86
  South Africa          175           8.9                                      60                    2029         1529             4.0                         3.0                                                                5.1    3.9    0.75

The percentage in the ratio of the crude rate of mortalities and the crude rate of incidences.

We also analyzed the association between the rates of incidence/mortality and the WHO ranking or e/GDP (SF1 and SF2). The results showed no significant association, except for the WHO ranking and the ASR of mortality (*P* = 0.005, SF2D). However, the use of the MIR for analyses revealed significant associations for both the WHO ranking and e/GDP and the MIR of the 57 countries (R^2^ = 0.195, *P* = 0.001; *R*^2^ = 0.195, *P* = 0.001, respectively, Figure [1](#F1){ref-type="fig"}).

![The (A) World Health Organization rankings and (B) total expenditures on health/gross domestic product are significantly associated with MIR in gastric cancer.](WJG-23-7881-g001){#F1}

DISCUSSION
==========

In this study, we analyzed the correlation of the incidence, mortality and MIRs for gastric cancer with WHO rankings and e/GDP. The MIR, which was calculated as the ratio of the crude rate of mortality and the crude rate of incidence, is regarded as an important marker for cancer care disparities. The crude rates of incidence and mortality, which our results showed were higher in Japan and Korea, are similar to those reported previously\[[@B22]\]. The incidence of gastric cancer can be influenced by environmental hygiene, food storage, diet habits, ethnicity, geographic regions, and, most importantly, age\[[@B23]\].

Otherwise, in countries with high incidence of gastric cancer, more frequent survey or detection of cancer is performed. This might result in more cases detected in early stage and contribute to good clinical outcome. It is also observed in this database that countries with higher incidence of gastric cancer have lower MIR compared with those with lower incidence (crude rate *vs* MIR: R^2^ = 0.104, *P* = 0.015; case number *vs* MIR: MIR: R^2^ = 0.078, *P* = 0.035). Otherwise, a better WHO ranking and a higher e/GDP were correlated linearly with a longer life expectancy (R^2^ = 0.0.689, *P* \< 0.001; R^2^ = 0.248, *P* \< 0.001 respectively). This could explain the lack of a significant association between the WHO rankings, e/GDP, and incidence of gastric cancer in our analysis.

The mortality rates for gastric cancer can be reduced by screening programs, early endoscopic detection and management, surgical intervention availability\[[@B24],[@B25]\], and the capability for chemotherapy or targeted therapy\[[@B26]\]. This may be why the ASR of mortality for gastric cancer was correlated with the WHO ranking, but had no significant correlation with total e/GDP. Previous data have shown that MIRs are lower in areas with better health care, and the present study shows that MIRs are also significantly lower in countries with better WHO rankings, with higher e/GDP, and in more developed regions. For the sex difference in the MIR and the health care disparities, previous study has shown that female patients with bladder cancer have higher MIR compared with male patients with bladder cancer\[[@B27]\]. However, unlike bladder cancer, there is no significant association in gastric cancer.

The limitations of this study include the fact that many countries are not participants in the WHO, and many of these countries are located in the least developed areas of the world. This limitation could influence the impact of e/GDP on gastric cancer incidence. Second, the use of the WHO rankings and e/GDP to represent the health care disparities of a country is not particularly specific. We were also unable to analyze ethnicity and national health insurance issues in our study. The reason why only the ASR mortality rate had a significant correlation with WHO rankings needs further investigation.

Our study indicates that gastric cancer has a higher incidence, mortality, and MIR value in less developed regions. Although the incidence, mortality, and MIR values are low in more developed regions, some differences were evident between the geographic regions; for example, the ASR incidence (9.4 *vs* 15.8 *vs* 3.8) and mortality (6.9 *vs* 11.7 *vs* 3.5) were higher in Europe and Asia than in Africa. The MIRs are generally lower in the more developed continents, as exemplified by North America, which showed the lowest MIR (0.56) and Africa, which showed the highest (0.91).

In conclusion, MIRs showed a significant correlation with WHO rankings and e/GDP in our analysis and we believe that this finding reflects the health care disparities of different countries. Our study provides a valuable documentation of the MIR and its relationship to the global geographic distribution of gastric cancer in 57 countries worldwide.
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